BiochemistrybioRxivPreprint
Chemoproteomic Profiling Reveals that Anti-Cancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3
B. P. Belcher, P. A. Machicao, B. Tong…·D. K. Nomura
This study identifies dankastatin B as a covalent inhibitor of VDAC3 in breast cancer cells, revealing its mechanism of action through chemoproteomic profiling.
DOI 10.1101/2023.02.11.528139